COVID-19 Outbreak Information –

Jane Salik

Member of the Board of Directors of PolyPeptide Group

Jane Salik, Member of the Board of Directors of PolyPeptide Group, is an American citizen born in 1953. Ms Salik was PolyPeptide’s CEO from 2006 until the listing of the company on 29 April 2021 and will remain a member of the Executive Committee as an Executive Board Member during an interim period planned to end with the company’s 2021 half-year results announcement. She has served on the Board of Directors of PolyPeptide Laboratories Holding B.V. since 2003. She joined the company in 1996 as President of PolyPeptide Laboratories Inc., where she was responsible for Sales and Marketing, and overall Management, Administration and Strategic Planning. Before her tenure at PolyPeptide, Ms. Salik worked for Bachem California as Vice President of Sales and Marketing (between 1986-1996). Prior to that, she served as technical services biochemist, product manager and marketing manager at Boehringer Mannheim (Indianapolis) starting 1980. Ms. Salik holds a PhD in Molecular and Cellular Biology from SUNY Stony Brook, New York and a B.A. in Biology from Lafayette College, Easton, Pennsylvania.